[SCHEDULE 13G/A] Cross Country Healthcare Inc SEC Filing

Rhea-AI Filing Summary

Cross Country Healthcare disclosed that The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC jointly hold 1,887,473.57 shares of its common stock, equal to 5.8% of the class. The filing identifies GS Group as a parent holding company and Goldman Sachs & Co. LLC as a broker-dealer and registered investment adviser that may own the securities on the parent’s behalf. The reporting parties certify the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The filing includes a joint filing agreement and an exhibit identifying the subsidiary relationship.

Positive

• Material ownership disclosed: Reporting persons state ownership of 1,887,473.57 shares (5.8%) of CCRN common stock.
• Passive intent certified: The filers certify the shares are held in the ordinary course of business and not to change or influence control of the issuer.
• Parent–subsidiary identification: Exhibit (99.2) identifies GS Group as parent and Goldman Sachs & Co. LLC as a subsidiary broker-dealer and registered investment adviser.
• Joint filing agreement included: Exhibit (99.1) records agreement between reporting parties to file jointly and permit amendments.

Negative

• None.

Insights

Financial Analyst

TL;DR: Goldman Sachs reports a material, disclosed passive stake (5.8%) in CCRN; ownership is significant but stated as non-control.

The report shows a beneficial ownership of 1,887,473.57 shares representing 5.8% of Cross Country Healthcare's common stock. The filing is a Schedule 13G/A and includes a certification that the holdings are held in the ordinary course of business and not to influence control. For investors, this is a material ownership disclosure because it crosses the 5% threshold, but the filing explicitly characterizes the position as passive.

Corporate Governance Expert

TL;DR: The disclosure documents a parent–subsidiary reporting structure and a joint filing agreement, with no declared intent to exert control.

Exhibit information identifies The Goldman Sachs Group, Inc. as a parent holding company and Goldman Sachs & Co. LLC as a subsidiary broker-dealer and registered investment adviser that may be the owner of the securities on the parent’s behalf. The filing includes a joint filing agreement authorizing joint and amended filings. The parties explicitly state the securities were not acquired to change or influence control, limiting immediate governance implications.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

CROSS COUNTRY HEALTHCARE, INC.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

227483104

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 227483104

1

Names of Reporting Persons

THE GOLDMAN SACHS GROUP, INC.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,887,051.57
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,887,473.57

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,887,473.57

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

CUSIP No. 227483104

1

Names of Reporting Persons

GOLDMAN SACHS & CO. LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,887,051.57
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,887,473.57

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,887,473.57

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

BD, OO, IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CROSS COUNTRY HEALTHCARE, INC.
(b)	Address of issuer's principal executive offices: 6551 PARK OF COMMERCE BOULEVARD, N.W., BOCA RATON, X1, 33487
Item 2.
(a)	Name of person filing: THE GOLDMAN SACHS GROUP, INC.| GOLDMAN SACHS & CO. LLC
(b)	Address or principal business office or, if none, residence: The Goldman Sachs Group, Inc. 200 West Street New York, NY 10282| Goldman Sachs & Co. LLC 200 West Street New York, NY 10282
(c)	Citizenship: THE GOLDMAN SACHS GROUP, INC. - Delaware| GOLDMAN SACHS & CO. LLC - New York
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP No.: 227483104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: See the response(s)to Item 11 on the attached cover page(s).
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit (99.2)
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

THE GOLDMAN SACHS GROUP, INC.

Signature:	Name: AMEEN SOETAN
Name/Title:	Attorney-in-fact
Date:	07/17/2025

GOLDMAN SACHS & CO. LLC

Signature:	Name: AMEEN SOETAN
Name/Title:	Attorney-in-fact
Date:	07/17/2025

Exhibit Information

EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of CROSS COUNTRY HEALTHCARE, INC. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. Date: 07/17/2025 THE GOLDMAN SACHS GROUP, INC. By:/s/ AMEEN SOETAN ---------------------------------------- Name: AMEEN SOETAN Title: Attorney-in-fact GOLDMAN SACHS & CO. LLC By:/s/ AMEEN SOETAN ---------------------------------------- Name: AMEEN SOETAN Title: Attorney-in-fact EXHIBIT (99.2) ITEM 7 INFORMATION The securities being reported on by The Goldman Sachs Group, Inc. ("GS Group"), as a parent holding company, are owned, or may be deemed to be beneficially owned, by Goldman Sachs & Co. LLC ("Goldman Sachs"), a broker or dealer registered under Section 15 of the Act and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. Goldman Sachs is a subsidiary of GS Group.

FAQ

What stake did Goldman Sachs disclose in Cross Country Healthcare (CCRN)?

The filing reports 1,887,473.57 shares beneficially owned, representing 5.8% of CCRN's common stock.

Who filed the Schedule 13G/A for CCRN?

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC jointly filed the Schedule 13G/A.

Does the filing say Goldman Sachs intends to influence control of CCRN?

No. The filers certify the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

What class of securities is reported in the CCRN filing?

The filing covers Common Stock, par value $0.0001 per share of Cross Country Healthcare.

Is there a joint filing agreement between the reporting parties?

Yes. Exhibit (99.1) is a joint filing agreement authorizing joint filing and amendments.

Does the filing identify any subsidiary relationship?

Yes. Exhibit (99.2) states that Goldman Sachs & Co. LLC is a subsidiary of The Goldman Sachs Group, Inc., and may own the reported securities on the parent’s behalf.